2K
Downloads
43
Episodes
The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change. From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events. The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.
Episodes
Monday May 03, 2021
Monday May 03, 2021
This meeting of the Commission took place on March 12, 2015. See here for more information on this event.
Panel One: The Biosurveillance and Detection Landscape Discussion of key elements of effective biosurveillance and detection, and continued challenges in the effectiveness of ongoing efforts.
- Dr. Julie Gerberding, Executive Vice President for Strategic Communications, Global Public Policy and Population Health, Merck; former Director, Centers for Disease Control and Prevention
- Dr. Julie Fischer, Associate Research Professor, Department of Health Policy, George Washington University
- Dr. Norm Kahn, Consultant, Counter-BIO LLC; former Director, Intelligence Community Counter-Biological Weapons Program
Panel Two: Environmental Surveillance and Detection Discussion of the technological and policy challenges to early and reliable detection of environmentally dispersed biological and chemical agents.
- Dr. Jeffrey Runge, President, Biologue, Inc.; former Chief Medical Officer and Assistant Secretary for Health Affairs, Department of Homeland Security
- Dr. Denise Pettit, Assistant Director, State Laboratory of Public Health, North Carolina Department of Health and Human Services
- Dr. Eric Van Geison, Senior Director, Diagnostics and Biosurveillance, Innovation, Global Health, and Security Operations, MRI Global; former Division Chief for Diagnostics and Disease Surveillance, Defense Threat Reduction Agency
Lunch Keynote: The Human-Animal Interface
- Dr. William B. Karesh, Executive Vice President for Health and Policy, EcoHealth Alliance
Panel Three: Clinical Surveillance and Detection Discussion of key elements of an effective clinical surveillance and detection architecture, and impediments to and opportunities in increasing situational awareness for early and accurate disease detection and clinical diagnosis.
- Dr. Dan Didier, Director of Public Health, Thermo Fischer Scientific • Mr. Dan Desmond, President, The SIMI Group
- Ms. Deborah Rosenblum, Executive Vice President, Nuclear Threat Initiative
- Mr. Robert VanDine, Founder, Rapid Pathogen Screening
Panel Four: Law Enforcement, Attribution, and the Lone Wolf Discussion of law enforcement activities, attribution of deliberate acts, and the problem of the lone wolf.
- Dr. Randall Murch, Professor in Practice, School of Public and International Affairs and Research Leader, Office of the Vice President, National Capital Region, Virginia Polytechnic Institute and State University (Virginia Tech)
- Dr. Yonah Alexander, Director, Inter-‐University Center for Terrorism Studies
- Supervisory Special Agent Edward You, Federal Bureau of Investigations Weapons of Mass Destruction Directorate
Panel Five: Read-outs from Study Panel Satellite Meetings Representatives from satellite meetings held in support of the Study Panel will present their findings and recommendations, providing a preview into response and recovery issues to be addressed at Meeting 4.
- Dr. Elizabeth Posillico, Co-‐Chair, Alliance for Biosecurity
- Dr. Gerald W. Parker, Vice President, Public Health Preparedness and Response, Texas A&M Health Sciences Center
- Ms. Beth Maldin Morgenthau, Assistant Commissioner, Bureau of Policy, Community Resilience and Response, Office of Emergency Preparedness and Response, NYC Department of Health and Mental Hygiene
- Mr. Tim Stephens, CEO, MESH Coalition
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.